All Venture Capital articles
-
White papersClimate investing in a constrained world
How structural bottlenecks are expanding the opportunity beyond cleantech to modernize systems running the physical economy.
-
VideoNeuberger Private Markets: Q2 2026 Preliminary Valuation Summary & Analysis
Doug Manor, Managing Director, Neuberger Private Markets, provides an overview of private equity markets and an outlook based on trends in the marketplace.
-
White papersHarvesting the Valuation Gap: The Strategic Role of Crossover Equity
Promising companies are choosing to fund their explosive growth in the private markets, creating a potentially attractive arbitrage for experienced “crossover equity” investors.
-
Asset Manager NewsHidden Hill Capital Invests in CorePilot with Strategic Support from HKIC
Shanghai and Singapore, 25 August 2026 – GLP’s Hidden Hill Capital (“Hidden Hill”) in its capacity as general partner (GP) and fund manager of its growth investment focused limited partnership fund (LPF) with the Hong Kong Investment Corporation (HKIC), has completed an investment in CorePilot (启芯领航), a leading China-based Electronic Design Automation (EDA) company headquartered in Shanghai.
-
White papersLooking beyond mega-caps
AI-focused capital flows are reshaping private markets, concentrating capital, and creating consensus exposure. We believe this dynamic has contributed to a growing divide between large-and mega-cap (predominantly) AI companies and perhaps overlooked small- and mid-cap opportunities often found in sectors outside of AI.
-
White papersFrom invention to investment: The case for UK venture capital
Britain is one of the world’s great originators of ideas, yet too many of its most promising companies have had to look abroad for the capital to grow. Institutional investors have a rare chance to fund the next stage of that growth story and capture compelling long-run return streams.
-
White papersThe IPO market inflection
How a new cohort of large AI-driven companies could reshape liquidity and market structure
-
White papersPrivate biotech investing deep dive
Private biotech sits apart from traditional venture capital and growth equity for three key reasons. First, the potential for value creation is driven by clinical inflection points (scientific derisking) instead of revenue growth or operating scale. Second, outcomes at key readouts are often binary rather than incremental, producing wider dispersion. Finally, as private biotech companies are generally pre-revenue, they remain capital-dependent throughout their life cycle.
-
White papersArticle Tech IPOs play leapfrog
Disruption may turn yesterday’s winners into tomorrow’s also rans.
-
VideoNeuberger Private Markets: Q1 2026 Preliminary Valuation Summary & Analysis
Doug Manor, Managing Director, Neuberger Private Markets, provides an overview of private equity markets and an outlook based on trends in the marketplace.
-
White papersThe convergence of public and private markets – a three-part full-picture perspective
Companies and issuers now operate in a capital landscape where public and private markets are continually intersecting. Across equity and debt, the traditional paradigms are breaking down, with participants more actively evaluating a range of financing options. We believe that the primary driver for this change is access to a much larger toolkit, requiring a more nuanced decision matrix. This involves weighing not only the cost of capital, but also considerations of flexibility, governance, and long-term strategic needs, among many other factors.
-
White papersManaging and executing innovation in asset management
A Q&A with Mark Versey, CEO of Aviva Investors, and Alastair Sewell, Senior Investment Director
-
White papersWhy private equity matters: From financial engineering to building better businesses
Private equity has a richer and more instructive history than most clients realize, and understanding that history changes how they think about the asset class today. In this installment of The Lead Left, Churchill’s Randy Schwimmer traces private equity’s evolution from family-funded deals before World War II through the leveraged buyout era to today’s operationally driven approach, and explains why that journey matters for evaluating managers in the current environment. If you’re building client confidence in private equity allocations, this is a compelling place to start. Explore the full piece here.
-
White papers2026 Europe - Life Sciences, Sector Update
The life sciences industry in the UK has transformed in the last few years. The growth of the sector has been supported by the requirements for medical advancements, improving therapies and technologies, and strong capital investment. With these factors driving the sector forward, real estate requirements have also evolved alongside the growth of occupiers in this space.
-
VideoVenture Capital Roundtable (3/3): What investors may be underestimating in 2026
What might investors be overlooking as they look ahead to 2026? From biotech shifts to climate resilience and distribution, our panel explores the themes that could shape future outcomes in part 3 of the venture capital roundtable series.
-
VideoVenture Capital Roundtable (2/3): How investors are identifying quality in a crowded market
With more companies and capital competing for attention, identifying true quality is increasingly complex. Part 2 of the venture capital roundtable series, our investors share how they cut through the noise to find differentiated opportunities.
-
VideoVenture Capital Roundtable (1/3): Where to look beyond AI in today’s market
As AI dominates investor attention, where might opportunities be missed? In the first video discussion of this series, our venture investors look beyond the headlines to uncover areas that may be underappreciated.
-
White papersMacro-factors revisited: an evolving approach to portfolio resilience
This paper revisits and builds upon our 2024 research on macro-factor exposures across public and private markets, with a particular focus on private infrastructure.
-
VideoNeuberger Private Markets: Q4 2025 Preliminary Valuation Summary & Analysis
Doug Manor, Managing Director, Neuberger Private Markets, provides an overview of private equity markets and an outlook based on trends in the marketplace.
-
Asset Manager NewsGLP’s Hidden Hill Capital Establishes RMB 500 Million Clean Energy Advanced Materials Fund
Shanghai and Singapore, 28 October 2025 – Shanghai and Singapore, 28 October 2025 - GLP’s Hidden Hill Capital (“Hidden Hill”), the private equity arm of GLP China, announced the closing of a new clean energy advanced materials fund with RMB 500 million of equity commitments. The Fund was anchored by Tianqi Lithium, a leading new energy materials company, and Anhui Advanced Materials Industry Strategic Investment Fund.
